title: Advances in neurofibromatosis 2 (NF2): a workshop report.
authors.affiliation: House Ear Institute, 2100 West Third Street, Los Angeles, CA 90027, USA. dlim@hei.org
authors.forename: D J
authors.initials: DJ
authors.lastname: Lim
authors.forename: A E
authors.initials: AE
authors.lastname: Rubenstein
authors.forename: D G
authors.initials: DG
authors.lastname: Evans
authors.forename: T
authors.initials: T
authors.lastname: Jacks
authors.forename: B G
authors.initials: BG
authors.lastname: Seizinger
authors.forename: M E
authors.initials: ME
authors.lastname: Baser
authors.forename: D
authors.initials: D
authors.lastname: Beebe
authors.forename: D E
authors.initials: DE
authors.lastname: Brackmann
authors.forename: E A
authors.initials: EA
authors.lastname: Chiocca
authors.forename: R G
authors.initials: RG
authors.lastname: Fehon
authors.forename: M
authors.initials: M
authors.lastname: Giovannini
authors.forename: R
authors.initials: R
authors.lastname: Glazer
authors.forename: J F
authors.initials: JF
authors.lastname: Gusella
authors.forename: D H
authors.initials: DH
authors.lastname: Gutmann
authors.forename: B
authors.initials: B
authors.lastname: Korf
authors.forename: F
authors.initials: F
authors.lastname: Lieberman
authors.forename: R
authors.initials: R
authors.lastname: Martuza
authors.forename: A I
authors.initials: AI
authors.lastname: McClatchey
authors.forename: D M
authors.initials: DM
authors.lastname: Parry
authors.forename: S M
authors.initials: SM
authors.lastname: Pulst
authors.forename: V
authors.initials: V
authors.lastname: Ramesh
authors.forename: W J
authors.initials: WJ
authors.lastname: Ramsey
authors.forename: N
authors.initials: N
authors.lastname: Ratner
authors.forename: J L
authors.initials: JL
authors.lastname: Rutkowski
authors.forename: M
authors.initials: M
authors.lastname: Ruttledge
authors.forename: D E
authors.initials: DE
authors.lastname: Weinstein
mesh_terms: D000328:Adult; D017668:Age of Onset; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002352:Carrier Proteins / Q000502:physiology; D002386:Cataract / Q000235:genetics; D002478:Cells, Cultured; D002892:Chromosomes, Human, Pair 22 / Q000235:genetics; D002986:Clinical Trials as Topic; D004252:DNA Mutational Analysis; D004195:Disease Models, Animal; D018450:Disease Progression; D004331:Drosophila melanogaster / Q000235:genetics; D005260:Female; D015870:Gene Expression; D018390:Gene Targeting; D017344:Genes, Insect; D016515:Genes, Neurofibromatosis 2; D015316:Genetic Therapy; D005838:Genotype; D006040:Goals; D006222:Hamartoma / Q000235:genetics; D006801:Humans; D019476:Insect Proteins / Q000235:genetics; D046911:Macromolecular Substances; D008297:Male; D008565:Membrane Proteins / Q000737:chemistry / Q000235:genetics / Q000502:physiology; D008577:Meningeal Neoplasms / Q000235:genetics; D008579:Meningioma / Q000235:genetics; D051379:Mice; D008817:Mice, Mutant Strains; D008840:Microfilament Proteins / Q000235:genetics / Q000502:physiology; D023421:Models, Animal; D009030:Mosaicism; D016518:Neurofibromatosis 2 / Q000453:epidemiology / Q000235:genetics / Q000473:pathology / Q000628:therapy; D025581:Neurofibromin 2; D009464:Neuroma, Acoustic / Q000235:genetics; D010641:Phenotype; D020033:Protein Isoforms / Q000737:chemistry / Q000502:physiology; D012164:Retinal Diseases / Q000235:genetics; D012583:Schwann Cells / Q000166:cytology; D012878:Skin Neoplasms / Q000235:genetics; D013125:Spinal Neoplasms / Q000235:genetics; D013049:Spectrin
chemical_list: D000970:Antineoplastic Agents; D002352:Carrier Proteins; D019476:Insect Proteins; D046911:Macromolecular Substances; D008565:Membrane Proteins; D008840:Microfilament Proteins; D025581:Neurofibromin 2; D020033:Protein Isoforms; D013049:Spectrin; C099885:merlin, Drosophila; C071058:moesin